Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Learn about VE303, a potential first-in-class Live Biotherapeutic Product for preventing recurrent Clostridioides difficile infection (rCDI).

According to the company’s website, Florastor adheres to strict standards for quality control and manufactures products in a CGMP certified facility. It’s unclear whether Florastor probiotics ...

Clostridium difficile infection (CDI) is considered to be the main cause of bacterial infectious diarrhea in nosocomial settings. Since the beginning of the new century a continuous rise in the ...

Why we love it: Florastor Daily Probiotic contains a probiotic yeast called Saccharomyces boulardii that research suggests may be helpful for managing symptoms of inflammatory bowel disease (IBD).

This indicator covers the incidence of healthcare associated infections from Clostridium difficile (C. diff). It measures outcomes that reflect the quality of care or processes linked by evidence to ...

Tinidazole is a structural analog of metronidazole and has been available in Europe for more than 2 decades. After activation, its toxic intermediates covalently bind to DNA, resulting in DNA ...

A new systematic review and network meta-analysis confirms that faecal microbiota transplantation is the most effective treatment for Clostridioides difficile infection. Learn more.

Let's start with the quote from GNOME developer site. The single most important rule when writing code is this: check the surrounding code and try to imitate it. As a maintainer it is dismaying to ...